Amgen Inc. (AMGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN)

AMGN 342.51

-0.5%

Nov 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick K who wrote (408)	11/18/1997 10:21:00 PM
From: Alan C. Zezula	Read Replies (1) of 1906

Elamex hasn't even begun the application process for approval by the FDA. I think this will be a saving grace for Amgn as they move slower than molasses in Jan. for approvals. Plus it doesn't sound like the patent infringement suit has been settled just yet. News was out on 17th. Amgn today 52 1/4 -- 11/16. If it were to have a terribly adverse affect on Amgn wouldn't it have been reflected in today's trading? Al

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next